Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Efficacy and Safety of Once Daily Oral Semaglutide in Adults With Overweight or Obesity
Novo Nordisk A/S
450 participants
Aug 12, 2026
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body weight when compared to 'dummy' tablets (placebo). Results from this study will help select the most optimal lower dose of oral semaglutide that can be used for treating participants living with overweight or obesity.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will receive semaglutide orally.
Participants will receive placebo orally.
Locations(62)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07770841